Thanh bên bài viết
Ngày xuất bản:
11/07/2022
Ngày xuất bản Online:
11/07/2022
Số lượt xem tóm tắt: 53
Số lượt xem PDF: 313
Số lượt xem PDF: 313
Số xuất bản
Chuyên mục
Nghiên cứu khoa học
Trích dẫn bài báo
Bùi, V. L., & Lê , T. L. (2022). TÁC DỤNG KHÔNG MONG MUỐN TRONG CHỤP CỘNG HƯỞNG TỪ (MRI). Tạp chí Điện quang & Y học hạt nhân Việt Nam, 11, 490-495. https://doi.org/10.55046/vjrnm.11.307.2013
TÁC DỤNG KHÔNG MONG MUỐN TRONG CHỤP CỘNG HƯỞNG TỪ (MRI)
Nội dung chính của bài viết
Chi tiết bài viết
Tài liệu tham khảo
TÀI LIỆU THAM KHẢO
1. KANAL E. Salety considerations in MR Imaging. Raliology 1990, 176: 593-606.
2. POHOST GM, BLACKWELL GG, SHEUOCK FG. Safety of patients with medical devices during application of magnetic resonance methods. Ann N Y Acad Sci 1992, 649: 302-312.
3. KANAL E. An overview of electromagnetic safety considerations associated with magnetic resonance imaging. Ann N Y Acad Sci 1992, 649: 204-224.
4. MENON DK, PEDEN CJ, HAU AS, SARGENTONI J. WHITWAM JG. Magnetic resonance for the anaesthetist. Part 1: Physical principles, applications, safety aspects. Anaesthesia 1992, 47: 240-255.
5. BUDINGER TF. Emerging nuclear magnetic resonance technologies. Health and salety. Ann N Y Acad Sci 1992, 649.
6. ATHEY TW. Current FDA guidance for MR patient exposure and considerations for the future. Ann N Y Acad Sci 1992, 649.
7. GUÉNEL P. LELLOUCH J. Effets des champs électriques et magnétiques de très basse frequence sur la sante. Éditions INSERM, Paris, 1992.
8. CARR JJ. Magnetic resonance contrats agents for neuroimaging. Salety issues. Neuroimaging Clin N Am 1994, 4: 43-54.
9. RUNGE VM, GELBLUM DY, PACETTI ML CAROLAN F. HEARD G. Gd-HP-DO3A in clinical MR imaging of the brain. Radiology 1990, 177: 393-400.
10. BARNHART JL, KUHNERT N. BAKAN DA, BERK RN. Biodistribution of GdC13 and Gd- DTPA and their infl uenoe on proton magnetic relaxation in rat tissues. Magn Reson Imag 1987,5: 221-231.
1. KANAL E. Salety considerations in MR Imaging. Raliology 1990, 176: 593-606.
2. POHOST GM, BLACKWELL GG, SHEUOCK FG. Safety of patients with medical devices during application of magnetic resonance methods. Ann N Y Acad Sci 1992, 649: 302-312.
3. KANAL E. An overview of electromagnetic safety considerations associated with magnetic resonance imaging. Ann N Y Acad Sci 1992, 649: 204-224.
4. MENON DK, PEDEN CJ, HAU AS, SARGENTONI J. WHITWAM JG. Magnetic resonance for the anaesthetist. Part 1: Physical principles, applications, safety aspects. Anaesthesia 1992, 47: 240-255.
5. BUDINGER TF. Emerging nuclear magnetic resonance technologies. Health and salety. Ann N Y Acad Sci 1992, 649.
6. ATHEY TW. Current FDA guidance for MR patient exposure and considerations for the future. Ann N Y Acad Sci 1992, 649.
7. GUÉNEL P. LELLOUCH J. Effets des champs électriques et magnétiques de très basse frequence sur la sante. Éditions INSERM, Paris, 1992.
8. CARR JJ. Magnetic resonance contrats agents for neuroimaging. Salety issues. Neuroimaging Clin N Am 1994, 4: 43-54.
9. RUNGE VM, GELBLUM DY, PACETTI ML CAROLAN F. HEARD G. Gd-HP-DO3A in clinical MR imaging of the brain. Radiology 1990, 177: 393-400.
10. BARNHART JL, KUHNERT N. BAKAN DA, BERK RN. Biodistribution of GdC13 and Gd- DTPA and their infl uenoe on proton magnetic relaxation in rat tissues. Magn Reson Imag 1987,5: 221-231.